Company name: Metamark Genetics
Industry: Oncology/medical device
Location: Cambridge, Massachusetts
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Solution/product: The company is developing two diagnostics for prostate cancer, according to a company statement. Its lead test is designed to use prostate cancer biopsy tissue to help physicians more accurately determine if patients have a slow-growing or aggressive form of prostate cancer, thereby improving treatment decisions. The second is designed to predict the longer-term course of disease.
Money raised: $13 million in a Series B round.
How it will be used: To advance the company’s clinical validation work. It will also be able to speed up diagnostic ans drug target research.
Management team: Mark Straley has resigned as the company’s president and CEO. Michael Kauffman is serving as interim executive director until a new CEO is hired. He previously co-founded oncology drug developer Karyopharm Therapeutics. Greg Critchfield. the lead director of the board, previously served as president and board member of Myriad Genetic Laboratories, the diagnostic subsidiary of Myriad Genetics, where he was responsible for launching seven novel molecular diagnostic products. Peter Blume-Jensen, the chief scientific officer, previously worked for Merck where he developed oncology drug discovery departments and programs linking therapeutics to patient responder populations, according to Metamark’s website.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Market: More than 214,600 men were diagnosed with prostate cancer in 2008, according to the Centers for Disease Control. In the same year, 28,471 died of the disease.
